![]() | Monter d'un niveau |
Cambay, F., Raymond, C., Brochu, D., Gilbert, M., Tu, T. M., Cantin, C., Lenferink, A., Grail, M., Henry, O., De Crescenzo, G., & Durocher, Y. (2020). Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors. Current Research in Immunology, 1, 23-37. Lien externe
Gaudreault, J., Forest‐Nault, C., Gilbert, M., Durocher, Y., Henry, O., & De Crescenzo, G. (2024). A low‐temperature SPR‐based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B. Biotechnology and Bioengineering, 15 pages. Disponible
Gaudreault, J., Forest-Nault, C./.H., Gilbert, M., Durocher, Y., Henry, O., & De Crescenzo, G. (2024). A low-temperature SPR-based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B. Biotechnology & Bioengineering, 121(5), 1659-1673. Lien externe
Mellahi, K., Brochu, D., Gilbert, M., Perrier, M., Ansorge, S., Durocher, Y., & Henry, O. (2019). Assessment of fed-batch cultivation strategies for an inducible CHO cell line. Journal of Biotechnology, 298, 45-56. Lien externe
Mellahi, K., Cambay, F., Brochu, D., Gilbert, M., Perrier, M., Ansorge, S., Durocher, Y., & Henry, O. (2019). Process development for an inducible rituximab-expressing Chinese hamster ovary cell line. Biotechnology Progress, 35(1), e2742. Lien externe
Mellahi, K., Brochu, D., Gilbert, M., Perrier, M., Ansorge, S., Durocher, Y., & Henry, O. (2019). Process intensification for the production of rituximab by an inducible CHO cell line. Bioprocess and Biosystems Engineering, 42(5), 711-725. Lien externe